Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

29 bottled water brands declared unsafe for consumption

ISLAMABAD: The government on Sunday announced that 29 brands of bottled water were unsafe for human consumption due to microbiological or chemical contamination. The government of Pakistan has directed the Pakistan Council for Research in Water Resources (PCRWR) to conduct quarterly monitoring of commercially available bottled and mineral water brands and publicise the results to create awareness…

29 bottled water brands declared unsafe for consumption

The Pakistani government announced on Sunday that 29 brands of bottled water are unsafe for consumption due to contamination. The Pakistan Council for Research in Water Resources (PCRWR) ordered quarterly monitoring of commercially available bottled and mineral water brands, publishing the results to raise public health awareness.

In the second quarter of 2026, 230 samples from 20 major cities were collected and compared to the Pakistan Standards and Quality Control Authority (PSQCA) standards. Nine brands, including HR Water Healthy Life and A2Z Pure Bottled Drinking Water, were unsafe due to high sodium levels, surpassing the safe limit of 50 ppm. Four brands, such as A2Z Pure Bottled Drinking Water and Imperial Pure Drinking Water, were found unsafe due to elevated total dissolved solids (TDS), exceeding the 500 ppm limit.

Twenty-two brands, including Mai Sial Bottled Drinking Water and Natural Pure Life (not Nestle), were contaminated with bacteria, making them unsuitable for drinking. The PCRWR urged consumers to refer to the detailed report for information on the safety status of their consumed bottled water brands, available on their website.

Written by urgent.news from Dawn - Pakistan's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.

Read the original at dawn.com →

More in Health & Medicine

Moderna-Merck cancer vaccine success marks breakthrough for personalised mRNA treatment

A PERSONALISED mRNA-based cancer vaccine developed by Moderna and Merck & Co. has delivered a landmark result in a late-stage melanoma trial, strengthening hopes that technology originally propelled…

  • Moderna and Merck's personalized mRNA cancer vaccine shows success in melanoma trial.
  • Vaccine reduces melanoma recurrence in post-surgery patients.
  • Treatment identifies and incorporates up to 34 tumor-specific mutations.

GC Biopharma Wins India, Taiwan Approvals

‘Hunterase’, a treatment for Hunter syndrome developed by GC Biopharma, has successively obtained product approval in major Asian countries India and Taiwan.GC Biopharma announced on August 24 that it…

  • GC Biopharma wins India, Taiwan approvals for Hunterase IV.
  • CDSCO grants India approval; TFDA approves ICV formulation.
  • Hunter syndrome affects 1 in 100,000 to 150,000 male children.

More from Monday 24 August →